134 related articles for article (PubMed ID: 20397266)
1. Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer.
Hermanova M; Karasek P; Tomasek J; Lenz J; Jarkovsky J; Dite P
World J Gastroenterol; 2010 Apr; 16(15):1879-84. PubMed ID: 20397266
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.
Hermanova M; Karasek P; Nenutil R; Kyr M; Tomasek J; Baltasova I; Dite P
Pancreas; 2009 Jul; 38(5):565-71. PubMed ID: 19346994
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
4. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
[TBL] [Abstract][Full Text] [Related]
5. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.
Beeghly-Fadiel A; Wilson AJ; Keene S; El Ramahi M; Xu S; Marnett LJ; Fadare O; Crispens MA; Khabele D
J Ovarian Res; 2018 Feb; 11(1):17. PubMed ID: 29482584
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
[TBL] [Abstract][Full Text] [Related]
7. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.
Matsumoto G; Muta M; Tsuruta K; Horiguchi S; Karasawa K; Okamoto A
Pancreatology; 2007; 7(2-3):167-73. PubMed ID: 17592230
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma.
Davis K; Dunseth CD; Mott SL; Cramer-Morales KL; Miller AM; Ear PH; Mezhir JJ; Bellizzi AM; Chan CHF
PLoS One; 2019; 14(3):e0213576. PubMed ID: 30856230
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.
Wang D; Guo XZ; Li HY; Zhao JJ; Shao XD; Wu CY
Tumour Biol; 2014 Oct; 35(10):10301-7. PubMed ID: 25034525
[TBL] [Abstract][Full Text] [Related]
13. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
[TBL] [Abstract][Full Text] [Related]
14. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
[TBL] [Abstract][Full Text] [Related]
15. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
16. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
18. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma.
Hu D; Ansari D; Zhou Q; Sasor A; Hilmersson KS; Bauden M; Jiang Y; Andersson R
BMC Cancer; 2018 Nov; 18(1):1096. PubMed ID: 30419838
[TBL] [Abstract][Full Text] [Related]
19. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
20. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]